awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50053733-C651D042-3222-4B96-8069-48AE82461BF5
Q50053733-C651D042-3222-4B96-8069-48AE82461BF5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50053733-C651D042-3222-4B96-8069-48AE82461BF5
Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab.
P2860
Q50053733-C651D042-3222-4B96-8069-48AE82461BF5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50053733-C651D042-3222-4B96-8069-48AE82461BF5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a6c22f35d4c4e62ed7498f7f60eb13250eb73120
P2860
Efficacy and safety of subcutaneous tabalumab, a monoclonal antibody to B-cell activating factor, in patients with systemic lupus erythematosus: results from ILLUMINATE-2, a 52-week, phase III, multicentre, randomised, double-blind, placebo-controll